Introduction {#s1}
============

Synaptic long-term potentiation (LTP) and long-term depression (LTD) are usually induced in the hippocampus by high frequency stimulation (HFS) and low frequency stimulation (LFS), respectively, and are commonly regarded as the cellular substrate for learning and memory (Bliss and Lomo, [@B10]; Staubli and Lynch, [@B69]; Bliss and Collingridge, [@B9]; Dudek and Bear, [@B15]; Bear and Malenka, [@B6]; Staubli and Ji, [@B68]; Martin et al., [@B45]). LTP and LTD are considered models of bidirectionally-changeable plasticity that are generally dependent on NMDA receptor (NMDAR) activation followed by postsynaptic Ca^2+^ influx, able to trigger Ca^2+^-dependent signaling pathways in many brain regions such as the hippocampus, in particular at the level of the Schaffer collateral-CA1 synapse (Bliss and Collingridge, [@B9]; Malenka and Nicoll, [@B44]; Malenka and Bear, [@B43]). Therefore, the direction of the change of synaptic strength depends on afferent stimulation causing different activation of NMDAR-dependent Ca^2+^ signaling (Dudek and Bear, [@B14], [@B15]; Mulkey and Malenka, [@B51]; Bear and Malenka, [@B6]; Cummings et al., [@B13]). Thus, a larger HFS-dependent Ca^2+^ entry leads to LTP (Bliss and Collingridge, [@B9]; Bear and Malenka, [@B6]), while moderate Ca^2+^ influx caused by LFS induces LTD in naïve synapses or de-potentiation (DP) in potentiated synapses (Staubli and Lynch, [@B69]; Dudek and Bear, [@B14], [@B15]; Bear and Malenka, [@B6]; Staubli and Ji, [@B68]).

Growing evidence suggest that the sex steroids 17β-estradiol (E2), testosterone (T) and 5α-dihydrotestosterone (DHT) may participate in rapidly modulating the long-term synaptic effects in different areas of the brain (McEwen, [@B46]; Isgor and Sengelaub, [@B35]; MacLusky et al., [@B42]; Hajszan et al., [@B28]) interacting with membrane receptors for E2 (ERs) and androgens (ARs; Kerr et al., [@B37]; Milner et al., [@B48], [@B47]; Kalita et al., [@B36]; Tabori et al., [@B70]; Pedram et al., [@B54]; Foradori et al., [@B19]; Morissette et al., [@B49]; Raz et al., [@B58]; Levin, [@B41]). In particular, it has been shown that E2 can increase the NMDAR-mediated glutamatergic transmission, decrease the GABAergic one and enhance the magnitude of LTP at hippocampal CA3-CA1 glutamatergic synapses (Wong and Moss, [@B75]; Woolley et al., [@B76]; Murphy et al., [@B52]; Foy et al., [@B21]; Foy, [@B20]; Rudick and Wooley, [@B62]; Smith and McMahon, [@B65], [@B66]; Smith et al., [@B67]; Hasegawa et al., [@B30]), while T and DHT show an opposite effect (Harley et al., [@B29]; Hebbard et al., [@B31]; Skucas et al., [@B64]; Hasegawa et al., [@B30]).

We recently reported that in hippocampal slices of male rats, estrogenic and androgenic signals are selectively involved in the induction of LTP or LTD/DP in response to specific synaptic activation (Pettorossi et al., [@B55]). Moreover, it has been found, by blocking ERs and ARs that E2 is implied in the LTP induced by HFS, while androgens in LTD/DP induced by LFS. This opposite influence of sex steroids on synaptic plasticity could be exerted by either the circulating steroids of gonadal origin or steroids synthesized in the nervous system from cholesterol (Baulieu, [@B5]; Compagnone and Mellon, [@B12]) and the subsequent conversion of T into E2 and DHT by P450-aromatase and 5α-reductase enzymes, respectively (Selmanoff et al., [@B63]; Kimoto et al., [@B38]; Hojo et al., [@B32], [@B34], [@B33]; Mukai et al., [@B50]). It is important to distinguish the specific influence of neurosteroids synthetized *de-novo* within the central nervous system (CNS) from that of circulating steroids since the neo-synthesis may directly reflect the functional conditions of CNS and may vary depending on the neuronal activity *per se* (Kimoto et al., [@B38]; Hojo et al., [@B32], [@B34], [@B33]; Balthazart and Ball, [@B1]; Balthazart et al., [@B3]; Mukai et al., [@B50]; Ooishi et al., [@B53]). The relevance of the sex neurosteroid synthesis is evidenced by their concentration in the nervous system that is significantly higher than that in the circulatory system (Selmanoff et al., [@B63]; Kimoto et al., [@B38]; Hojo et al., [@B32], [@B34], [@B33]; Mukai et al., [@B50]).

We previously reported that HFS-LTP is markedly reduced by the blocking agent for the P450-aromatase activity, letrozole (Grassi et al., [@B24], [@B27]; Tanaka and Sokabe, [@B71]; Vierk et al., [@B73], [@B72]), supporting the involvement of the E2 neo-synthesized within the CNS in the induction of LTP. However, the possible contribution of neo-synthesis of E2 in LTP and LTD induced by different stimulation patterns, or the role of the neo-synthesis of androgens in LTP and LTD has not been addressed.

Therefore, in the present study we directly assessed, in the hippocampal slices of male rat, the role of E2 and DHT neo-syntheses and their possible interaction in the induction of LTD/DP and LTP focusing on the Schaffer collateral-CA1 synaptic region where the LTP is known to be NMDAR dependent. For this purpose, we analyzed the effect of different stimulation patterns in the presence of inhibitors of the P450-aromatase and/or the 5α-reductase enzymes.

Material and Methods {#s2}
====================

Ethic Statement on Animal Use {#s2-1}
-----------------------------

All procedures on animals were conducted in conformity with the guidelines of the Italian Ministry of Health, national laws on animal research (Legislative Decree 26/2014) and European Communities Council Directive (86/609/ECC), in accordance with protocols approved by the Animal Care and Use Committee at the University of Perugia (Italy). Wistar rats (Harlan, Italy) (2 per cage) were kept under regular lighting conditions (12 h light/dark cycle) and given food and water *ad libitum*. All efforts were made to minimize the number of animals used and their suffering.

Electrophysiology {#s2-2}
-----------------

The study was conducted in 281 hippocampal slices prepared from 112 male Wistar rats at P50--60. We used male rats to avoid any possible influence of cyclic, systemic estrogenic fluctuation on the induction of synaptic plasticity (Warren et al., [@B74]; Good et al., [@B23]). Animals were sacrificed under deep halothane anesthesia, by cervical dislocation. The brain was rapidly removed and immersed for 2--3 min in ice-cold ACSF containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl~2~, 1.2 NaH~2~PO~4~, 2.4 CaCl~2~, 10 glucose, and 25 NaHCO~3~, continuously bubbled with 95% O~2~ and 5% CO~2~, pH 7.4. After the extraction of the hippocampus, 400 μm-thick transverse slices were cut in ice-cold ACSF with a vibratome (Series 1000 plus starter CE, Vibratome, St. Louis, MO, USA) and allowed to recover in oxygenated ACSF at room temperature for 2 h before experimental recordings.

Field Potential Recordings {#s2-3}
--------------------------

For each animal we used 2--3 slices. A slice was transferred into the recording chamber and submerged with ACSF at a constant rate of 2 ml/min at room temperature.

Extracellular recordings with borosilicate glass capillaries (GC150F-10; Harvard Apparatus) filled with 2M NaCl (resistance, 10--15 MΩ) were obtained from the apical dendritic layer of the CA1 region for analysis of population EPSPs. Synaptic responses were elicited by applying single stimuli pulses (duration: 20 μs and intensity: 20--50 mA) at a frequency of 0.05 Hz through a bipolar platinum-iridium stimulating electrode placed in the Schaffer collateral--commissural pathway. This stimulation evoked field EPSPs (fEPSPs) that were 50--70% of maximal slope. FEPSPs were filtered at 3 KHz, digitized at 10 KHz and stored on PC equipped with a data acquisition card (at-MIO-16E-2, National Instruments, Austin, TX, USA). An Axoclamp 2B amplifier (Molecular Devices, USA) was used for the recordings.

After a stable baseline recording for 20 min, LTD/DP or LTP was induced. For inducing LTD and DP we used a LFS protocol consisting of 15 min stimulation at 1 Hz applied at the same stimulus intensity. LTP was normally induced by HFS (a single 1 s-100 Hz tetanus) at the same stimulus intensity. In some experiments the LTP induction was investigated by using a single weak frequency stimulation (WFS, 1 s-25 Hz tetanus) or medium frequency stimulation (MFS, 1 s-50 Hz tetanus).

Drugs {#s2-4}
-----

E2 (0.5--1 nM), DHT (10--50 nM), T (50 nM), the specific inhibitor of the enzyme 5α-reductase finasteride (1 μM) (Finn et al., [@B18]) and the specific inhibitor of P450-aromatase enzyme letrozole (100 nM) (Bhatnagar et al., [@B7]) were used for the experiments. All drugs were purchased from Sigma-Aldrich (St Louis, MO, USA). Stock drug solutions were dissolved in DMSO, diluted to working concentration in oxygenated ACSF and perfused at a rate of 2 ml/min. Total replacement of the medium in the chamber occurred within 1 min. In the experiments in which the effect of LFS, HFS, WFS or MLF was analyzed in the presence of blocking agents, drugs were applied for all the recording period 15 min before the application of the stimulation protocol. The influence of drug vehicle (0.001% DMSO) on the induction of LTD/DP and LTP was excluded on the basis of analysis performed previously (Pettorossi et al., [@B55]).

Electrophysiological Data Analysis and Statistical Evaluation {#s2-5}
-------------------------------------------------------------

To characterize the drug effects on the baseline fEPSP and on the induction of the long-term effects caused by different stimulation protocols, testing stimuli were applied every 20 s. The initial slope of fEPSP was measured using linear regression of the first 0.8 ms succeeding the pre-synaptic fiber volley and the average response recorded during a stable period (10 min) at the beginning of the experiment was used as the baseline. The averaged fEPSP, calculated every 2 min, was expressed as percentage of the baseline fEPSP value and used for data presentation. In each experiment, the occurrence of LTD or LTP was statistically verified (Student's paired *t* test) by comparing the fEPSP slopes measured 40 min following the inducing stimulus relative to baseline responses. To prove the induction of DP (Staubli and Lynch, [@B69]; Dudek and Bear, [@B15]) we compared in each experiment (Student's paired *t* test) the pre-LFS fEPSP values with those measured 40 min after LFS. In addition, the effects of drugs on the baseline were evaluated by comparing (Student's paired *t* test) the pre-drug fEPSP values with those measured 10--15 min after the drug application. Moreover, the effects observed in different experimental conditions were compared by using the one-way analysis of variance (ANOVA) and the Tukey's *post hoc* test. The level of significance was set at *p* \< 0.05 for Student's *t* test, ANOVA and *post hoc* comparisons. Statistical analyses were performed with Statistica (StatSoft, Tulsa, OK, USA). Values given in the text are mean ± SEM, *n* representing the number of the slices.

Results {#s3}
=======

Role of DHT and E2 Neo-Syntheses in the Development of LFS-LTD {#s3-1}
--------------------------------------------------------------

### Inhibition of 5α-Reductase by Finasteride Prevents the Development of LFS-LTD {#s3-1-1}

In control condition LFS induced LTD of synaptic transmission reducing the fEPSP to 73.3 ± 3.4% (*n* = 9, 4 animals, Figures [1A,D](#F1){ref-type="fig"}). The application of finasteride did not change the baseline (pre-drug 100.6 ± 0.6% vs. post-drug 101.1 ± 0.4%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.51, Figure [1A](#F1){ref-type="fig"}), but it fully prevented LFS-LTD. A partial LTP was induced instead, since LFS enhanced the fEPSP to 148 ± 4.5% (*n* = 8, Figures [1A,D](#F1){ref-type="fig"}). This potentiation was significantly smaller than the LTP normally induced by HFS (Tukey's *post hoc* test, LFS + FIN vs. HFS control: *p* \< 0.001, Figure [1D](#F1){ref-type="fig"}). Moreover, finasteride applied following LFS-LTD induction had no effect (pre-drug 73.1 ± 4.6% vs. post-drug 73.7 ± 4.3%, *n* = 4, 2 animals, Student's *t* test, *p* = 0.39, data not shown).

![**Induction of long-term depression (LTD) by low frequency stimulation (LFS) depends on the synthesis of DHT. (A,C)** Effects of LFS in the presence of different drugs. On the top of panels **(A--C)** averaged traces (*n* = 20) of fEPSPs recorded before (thin traces) and 40 min after LFS (thick traces) in different experimental conditions. Graphs in this and following figures report mean ± SEM (*n* = number of slices) of the fEPSP slope evaluated within 2-min interval and expressed as a percentage of the baseline. The gray bars show the drug infusion time and the black bars the LFS delivering time. **(A)** Effect of LFS in control condition (filled circles), under finasteride (FIN, filled squares) and 50 nM DHT (open circles). **(B)** Effect of LFS in control condition (filled circles), under FIN + 50 nM DHT (open circles), FIN + 10 nM DHT (filled triangles) and FIN + 50 nM T (open triangles).**(C)** Effect of LFS in control condition (filled circles), under FIN (filled squares), letrozole (LET, open circles) and FIN + LET (half-filled squares). **(D)** Comparison of the fEPSP changes induced by high frequency stimulation (HFS) in control condition and by LFS under different drugs as shown in **(A--C)**. In this and following bar charts data represent mean ± SEM of the fEPSP slope (% of the baseline). Comparisons among long-term potentiation (LTP) (one-way analysis of variance (ANOVA), *F*~8,72~ = 54.2, *p* \< 0.0001; Tukey's *post hoc* test, \*\**p* \< 0.001; n.s. = no significant) and LTD (one-way ANOVA, *F*~3,29~ = 0.2, *p* = 0.85). Note that without synthesis of DHT, LFS is able to induce a partial LTP that is not dependent on the E2 synthesis.](fncel-09-00376-g0001){#F1}

### Exogenous DHT Rescues the LFS-LTD under 5α-Reductase Inhibition by Finasteride {#s3-1-2}

Application of 50 nM DHT did not modify either the baseline (pre-drug 100.7 ± 0.5% vs. post-drug 99.7 ± 0.2%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.18, Figure [1A](#F1){ref-type="fig"}) or the development of LFS-LTD (70.5 ± 2.5%, *n* = 8, Tukey's *post hoc* test, LFS + 50 nM DHT vs. LFS control: *p* = 0.99, Figures [1A,D](#F1){ref-type="fig"}), but it was able to fully rescue the LFS-LTD under finasteride (72.3 ± 2%, *n* = 8, 3 animals, Tukey's *post hoc* test, LFS + FIN + 50 nM DHT vs. LFS control, *p* = 0.99, Figures [1B,D](#F1){ref-type="fig"}). Conversely, this rescue did not occurr using lower concentration of DHT (10 nM) since LFS still induced a partial LTP (150.5 ± 2.1%, *n* = 8, 3 animals, Figure [1B](#F1){ref-type="fig"}, Tukey's *post hoc* test, LFS + FIN +10 nM DHT vs. LFS + FIN, *p* = 0.99, Figure [1D](#F1){ref-type="fig"}). In addition, we also applied 50 nM testosterone (T) under finasteride for rescuing LTD. T did not change the baseline (pre-drug 100.7 ± 0.4% vs. post-drug 100.6 ± 0.1%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.87, Figure [1B](#F1){ref-type="fig"}) and was not able to rescue the LFS-LTD since a partial LTP was induced, not different from that observed under finasteride alone (150.7 ± 2.8%, *n* = 8, Tukey's *post hoc* test, LFS + FIN +50 nM T vs. LFS + FIN: *p* = 0.99, Figures [1B,D](#F1){ref-type="fig"}).

Overall, these results on blockade of 5α-reductase provide evidence that the DHT synthesized *de-novo* plays a crucial role in the development of LFS-LTD, while T has no effect.

### Inhibition of P450-Aromatase by Letrozole does not Affect the Development of LFS-LTD {#s3-1-3}

Letrozole did not affect either the baseline (pre-drug 100.2 ± 0.2% vs. post-drug 100.7 ± 0.4%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.43, Figure [1C](#F1){ref-type="fig"}) or the development of LFS-LTD (74.8 ± 5%, *n* = 8, Tukey's *post hoc* test, LFS + LET vs. LFS control, *p* = 0.99, Figures [1C,D](#F1){ref-type="fig"}). In addition, the partial LTP observed under fiansteride was not modified when LFS was delivered under letrozole plus finasteride (152.7 ± 4.3%, *n* = 8, 3 animals, Tukey's *post hoc* test, LFS + FIN + LET vs. LFS + FIN, *p* = 0.98, Figures [1C,D](#F1){ref-type="fig"}). These data suggest that E2 neo-synthesis is not implied in the development of either LFS-LTD or LFS-small LTP.

### Exogenous E2 Reverts LFS-LTD into LFS-LTP {#s3-1-4}

In agreement with earlier reports (Foy et al., [@B21]; Bi et al., [@B8]; Kramár et al., [@B39]), infusion of 1 nM E2 caused a rapid increase of the fEPSP baseline (139.4 ± 5.1%, *n* = 8, 4 animals, Figure [2A](#F2){ref-type="fig"}). Subsequent application of LFS elicited LTP (193.9 ± 5.3%, *n* = 8, Figure [2A](#F2){ref-type="fig"}) that persisted at the E2 washout (195.1 ± 5.5%, Student's *t* test, *p* = 0.42) and was not different from the LTP induced by HFS (Tukey's *post hoc* test, LFS + 1 nM E2 vs. HFS control, *p* = 0.97, Figure [2B](#F2){ref-type="fig"}). The same effect was observed when LFS was delivered under E2 after adjusting the stimulation pulse strength (asE2) to produce responses equivalent in size to those recorded during pre-infusion baseline (LTP: 197.8 ± 3.2%, *n* = 8, 3 animals, Tukey's *post hoc* test, LFS + 1 nM asE2 vs. LFS + 1 nM E2, *p* = 0.87, LFS + 1 nM as E2 vs. HFS control, *p* = 0.99, Figures [2A,B](#F2){ref-type="fig"}). E2 used at lower concentration (0.5 nM) also increased the baseline (142.4 ± 3%, *n* = 8, 3 animals) similarly to what observed after 1 nM E2 (ANOVA: *F*~(1,\ 14)~ = 0.25; *p* = 0.68, Figure [2A](#F2){ref-type="fig"}). LFS delivered after adjusting the response to the pre-drug values induced LTP (174.5 ± 2.2%, *n* = 8, Figure [2A](#F2){ref-type="fig"}) that was lower than the one obtained in the presence of 1 nM asE2 (Tukey's *post hoc* test: LFS + 0.5 nM asE2 vs. LFS + 1 nM asE2, *p* \< 0.05, Figures [2A,B](#F2){ref-type="fig"}).

![**Exogenous administration of E2 reverts the LFS-LTD into LFS-LTP. (A)** Effect of LFS in the presence of 1 nM E2 (open triangles) without stimulus adjustment and 1 nM (filled triangles) or 0.5 nM E2 (half-filled triangles) with stimulus adjustment (as). **(B)** Comparison among LTP induced by HFS in control condition and by LFS in the presence of E2 at different concentrations and stimulus adjustment (one-way ANOVA, *F*~3,37~ = 2.86, *p* \< 0.05; Tukey's *post hoc* test, \**p* \< 0.05).](fncel-09-00376-g0002){#F2}

This result demonstrates that exogenously administered E2 is able to revert the LTD induced by LFS into LTP.

Role of E2 and DHT Neo-Synthesis in the Development of LTP Depotentiation {#s3-2}
-------------------------------------------------------------------------

### Inhibition of 5α-Reductase by Finasteride Prevents the LFS-DP {#s3-2-1}

In control condition HFS induced LTP (193.4 ± 3.5%, *n* = 9, 4 animals) and LFS delivered 30 min after induced DP reducing LTP to 147.8 ± 8% (*n* = 9, Student's *t* test, *p* = 0.003; Figure [3](#F3){ref-type="fig"}). Application of finasteride starting 15 min after HFS had no effect on the already settled LTP (pre-drug 192.4 ± 5.7% vs. post-drug 194.1 ± 5.8%, *n* = 8, 4 animals, Student's *t* test, *p* = 0.85, Figures [3A,B](#F3){ref-type="fig"}), but it prevented the LFS-DP (pre-LFS 194.1 ± 5.8% vs. post-LFS 194.5 ± 5.3%, *n* = 8, Student's *t* test, *p* = 0.82, Figures [3A,B,D](#F3){ref-type="fig"}).

![**Neo-synthesis of DHT is involved in the induction of DP by LFS. (A)** Effect of LFS in control condition (filled circles), under FIN (filled squares) and FIN + 50 nM DHT (open circles). **(B)** Effects of LFS in control condition (filled circles), under FIN (filled squares), LET (open squares) and FIN + LET (half-filled squares). **(C)** Effect of LFS in control condition (filled circles) and in the presence of 1 nM E2 (open triangles). The drugs were applied 15 min after the induction of HFS-LTP and LFS was delivered 30 min after HFS. In this and following figure the arrows indicate the HFS delivering time. **(D)** Comparison between HFS-LTP and LFS-DP in different conditions as shown in **(A--C)** (Student's *t* test, \**p* \< 0.05). The LFS-DP values in control condition and under different drugs are compared (one-way ANOVA, *F*~2,22~ = 0.049, *p* = 0.95). Note that the synthesis of DHT, but not that of E2, is required for the induction of LFS-DP, while exogenous E2 is able to prevent the LFS-DP.](fncel-09-00376-g0003){#F3}

Administration of 50 nM DHT under finasteride did not affect the induced LTP (pre-drug 194.1 ± 3.1% vs. post-drug 194.6 ± 3.5%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.8, Figure [3A](#F3){ref-type="fig"}), but it was able to rescue the LFS-DP (pre-LFS 194.6 ± 3.9% vs. post-LFS 140 ± 1.9%, *n* = 8, Student's *t* test, *p* \< 0.0001; Tukey's *post hoc* test: LFS + DHT + FIN vs. LFS control, *p* = 0.99, Figures [3A,D](#F3){ref-type="fig"}). On the whole, this result provides evidence that the DHT neo-synthesis plays a crucial role in the development of LFS-DP.

### Inhibition of P450-Aromatase by Letrozole does not Affect the Development of LFS-DP {#s3-2-2}

We also assayed the effects of letrozole alone and finasteride plus letrozole on the induction of LFS-DP. Letrozole did not modify the LTP once induced by HFS (pre-drug 193.8 ± 6.1% vs. post-drug 191.9 ± 5.8%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.37, Figure [3B](#F3){ref-type="fig"}), or the DP after LFS (pre-LFS 191.9 ± 5.8% vs. post-LFS 139.1 ± 6.4%, *n* = 8, Student's *t* test, *p* \< 0.001, Figure [3B](#F3){ref-type="fig"}, Tukey's *post hoc* test: LFS + LET vs. LFS control, *p* = 0.99, Figure [3D](#F3){ref-type="fig"}) and it did not rescue the DP when suppressed by finasteride (pre-LFS 192.7 ± 6.6% vs. post-LFS 194.5 ± 6%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.61, Figures [3B,D](#F3){ref-type="fig"}). Like observed for the LFS-LTD, these results further exclude a role of E2 neo-synthesis in the depressant effects induced by LFS.

### Exogenous E2 Prevents the LFS-DP {#s3-2-3}

We assayed whether exogenous E2 influenced the induction of LFS-DP. Application of 1 nM E2 starting 15 min after the induction of HFS-LTP had no effect on LTP (pre-drug 196.2 ± 9.6% vs. post-drug 195.6 ± 7.8%, *n* = 8, 3 animals, Student's *t* test, *p* = 0.82, Figure [3C](#F3){ref-type="fig"}), but it prevented the LFS-DP (pre-LFS 195.6 ± 7.8% vs. post-LFS 195.6 ± 8.7%, *n* = 8, Student's *t* test, *p* = 0.98, Figures [3C,D](#F3){ref-type="fig"}). This finding demonstrates that although the E2 neo-synthesis does not play any role in the LFS-DP, exogenous E2 is able to prevent it.

Role of E2 and DHT Neo-Synthesis in the Development of HFS-LTP {#s3-3}
--------------------------------------------------------------

### Effect of P450-Aromatase and 5α-Reductase Blockade on the Development of HFS-LTP {#s3-3-1}

In full agreement with our previous results (Grassi et al., [@B27]), HFS in the presence of letrozole induced LTP (129 ± 4.3%, *n* = 10, 4 animals, Figures [4A,B](#F4){ref-type="fig"}) that was significantly smaller than that obtained in the control condition (199.8 ± 7%, *n* = 17, 6 animals, Tukey's *post hoc* test: HFS + LET vs. HFS control, *p* \< 0.001, Figure [4D](#F4){ref-type="fig"}). By contrast, LTP induced under finasteride was markedly enhanced (296.5 ± 9.1%, *n* = 8, 3 animals, Tukey's *post hoc* test: HFS + FIN vs. HFS control, *p* \< 0.001, Figures [4A,D](#F4){ref-type="fig"}). In addition, the combined application of finasteride and letrozole caused LTP (165.3 ± 2.2%, *n* = 8, 3 animals, Figure [4A](#F4){ref-type="fig"}) of an amplitude that was in-between the control LTP and LTP under letrozole alone (Tukey's *post hoc* test: HFS + LET + FIN vs. HFS control, *p* \< 0.01, HFS + LET + FIN vs. HFS + LET, *p* \< 0.01, Figures [4A,D](#F4){ref-type="fig"}).

![**Neo-synthesis of E2 is involved in the full development of HFS-LTP. (A,B)** On the top averaged traces (*n* = 20) of fEPSPs recorded before (thin traces) and 40 min after HFS (thick traces) in different experimental conditions. **(A)** Effect of HFS in control condition (filled circles), under LET (open squares), FIN (filled squares) and LET + FIN (half-filled squares). **(B)** Effect of HFS in control condition (filled circles), in the presence of LET (open squares), 1 nM E2 (filled triangles), LET + 1 nM E2 (half-filled triangles) and LET + 0.5 nM E2 (open triangles). **(C)** Effect of HFS in control condition (filled circles) and in the presence of 50 nM DHT (open circles). **(D)** Comparison among LTP induced by HFS in control condition and under blockade of E2 and DHT synthesis as shown in **(A)** (one-way ANOVA, *F*~3,39~ = 87.7, *p* \< 0.0001; Tukey's *post hoc* test \*\**p* \< 0.001, \**p* \< 0.05). **(E)** Comparison among LTP induced by HFS in control condition, under exogenous DHT and E2 with or without LET (one-way ANOVA, *F*~5,54~ = 42.6, *p* \< 0.0001; Tukey's *post hoc* test \*\**p* \< 0.001). Note that for the full development of HFS-LTP the synthesis of E2 is mainly requested and the block of DHT synthesis further increases LTP.](fncel-09-00376-g0004){#F4}

These results demonstrate that the blockade of E2 and DHT synthesis remarkably alters the response to HFS by decreasing or increasing the amplitude of LTP, respectively.

### Exogenous E2 Rescues LTP When HFS is Delivered Under the P450-Aromatase Inhibitor Letrozole {#s3-3-2}

Application of exogenous 1 nM E2 increased the baseline fEPSP (136.1 ± 3.4%, *n* = 8, 3 animals, Figure [4B](#F4){ref-type="fig"}) and the HFS-LTP to 227.8 ± 3.2% (*n* = 8, Figure [4B](#F4){ref-type="fig"}) a value that was higher than that observed in the control condition (Tukey's *post hoc* test: HFS+1 nM E2 vs. HFS control, *p* \< 0.05, Figure [4E](#F4){ref-type="fig"}). This enhancement of LTP was observed after reducing the stimulus intensity to cancel the baseline increase.

Similarly, application of 1 nM E2 in the presence of letrozole enhanced the baseline (135.2 ± 3.8%, *n* = 8, 4 animals, Figure [4B](#F4){ref-type="fig"}) and rescued the HFS-LTP to a value (233.8 ± 7.3%, *n* = 8) that was not different from that observed after HFS under E2 alone (Tukey's *post hoc* test: HFS + LET + 1 nM E2 vs. HFS + 1 nM E2, *p* = 0.98, HFS + LET + 1 nM E2 vs. HFS + LET, *p* \< 0.001, Figures [4B,E](#F4){ref-type="fig"}). In addition, no difference was observed by using E2 at lower concentration (0.5 nM), either on the baseline (135.2 ± 2.4%, *n* = 8, 3 animals, Figure [4B](#F4){ref-type="fig"}) or on the HFS-LTP (239.6 ± 2.8%, *n* = 8, Tukey's *post hoc* test: LET + 0.5 nM E2 vs. LET + 1 nM E2, *p* = 0.98, Figures [4B,E](#F4){ref-type="fig"}).

### Exogenous DHT does not Influence the HFS-LTP {#s3-3-3}

We verified whether exogenous DHT might influence the development of LTP by delivering HFS in the presence of 50 nM DHT. DHT did not interfere with the HFS-LTP (194.7 ± 4.2%, *n* = 8, 3 animals, Tukey's *post hoc* test: HFS + 50 nM DHT vs. HFS control, *p* = 0.99, Figures [4C,E](#F4){ref-type="fig"}).

Different Involvement of DHT and E2 Neo-Synthesis in LTP Induced by WFS and MFS {#s3-4}
-------------------------------------------------------------------------------

By using WFS (1 s-25 Hz) a very small LTP was induced (114.8 ± 2.2%, *n* = 8, 4 animals, Figure [5A](#F5){ref-type="fig"}) compared with that induced by HFS (Tukey's *post hoc* test: WFS control vs. HFS control, *p* \< 0.001, Figure [5B](#F5){ref-type="fig"}). The contribution of the neo-synthesis of DHT and/or E2 in the induction of this small LTP was examined by applying finasteride, letrozole or finasteride plus letrozole. In the presence of finasteride WFS induced a robust LTP (157.4 ± 5.9%, *n* = 8, 3 animals, Tukey's *post hoc* test: WFS + FIN vs. WFS control, *p* \< 0.001, Figures [5A,B](#F5){ref-type="fig"}), while in the presence of letrozole LTP was not different from the control one (113.7 ± 2%, *n* = 8, 3 animals, Tukey's *post hoc* test: WFS + LET vs. WFS control, *p* = 0.99, WFS + LET vs. WFS + FIN, *p* \< 0.001, Figures [5A,B](#F5){ref-type="fig"}). The addition of letrozole to finasteride did not modify the amplitude of LTP compared to that induced under finasteride alone (162 ± 4.2%, *n* = 8, 3 animals, Tukey's *post hoc* test: WFS + FIN + LET vs. WFS + FIN, *p* = 0.98, WFS + FIN + LET vs. WFS + LET, *p* \< 0.001, WFS + FIN + LET vs. WFS control, *p* \< 0.001, Figures [5A,B](#F5){ref-type="fig"}). Conversely, MLF (1 s-50 Hz) induced LTP (196.8 ± 7.4%, *n* = 8, 4 animals, Figure [5C](#F5){ref-type="fig"}) that was not different from that induced by HFS (Tukey's *post hoc* test: MFS control vs. HFS control, *p* = 0.99, Figure [5D](#F5){ref-type="fig"}). This LTP was significantly reduced in the presence of letrozole (127.9 ± 1.6%, *n* = 8, 3 animals, Tukey's *post hoc* test: MFS + LET vs. MFS control, *p* \< 0.001, Figures [5C,D](#F5){ref-type="fig"}), but it was not changed under finasteride (201.3 ± 7.7%, *n* = 8, 3 animals, Tukey's *post hoc* test: MFS + FIN vs. MFS control, *p* = 0.95, Figures [5C,D](#F5){ref-type="fig"}). In addition, under combined application of letrozole and finasteride the amplitude of MLF-LTP (165.2 ± 2.4, *n* = 8, 3 animals, Figure [5C](#F5){ref-type="fig"}) was in-between the control and letrozole values (Tukey's *post hoc* test: MFS + FIN + LET vs. MFS control, *p* \< 0.05, MFS + FIN + LET vs. MFS + LET, *p* \< 0.01, Figure [5D](#F5){ref-type="fig"}). These results suggest that for the WFS long-term response the synthesis of DHT is involved, whereas E2 does not play any role. Conversely, the synthesis of E2 is only required for the development of a full LTP by MFS.

![**LTP induced by WFS (1 s-25 Hz) and MFS (1 s-50 Hz). (A)** Effect of WFS in control condition (filled circles), in the presence of FIN (filled squares), LET (open squares) and FIN + LET (half-filled squares). **(B)** Comparison among LTP induced by HFS in control condition and by WFS in the different conditions as shown in A (one-way ANOVA, *F*~4,44~ = 42.25, *p* \< 0.0001; Tukey's *post hoc* test \*\**p* \< 0.001). **(C)** Effect of MFS in control condition (filled circles), in the presence of FIN (filled squares), LET (open squares) and FIN + LET (half-filled squares). **(D)** Comparison among LTP induced by HFS in control condition and by MFS in the different conditions as shown in C (one-way ANOVA, *F*~4,43~ = 16.76, *p* \< 0.0001; Tukey's *post hoc* \*\**p* \< 0.001, \**p* \< 0.05). Note that the synthesis of DHT is mainly implied in the WFS induced LTP, while that of E2 is only involved in LTP induced by MFS.](fncel-09-00376-g0005){#F5}

Comparison of the Responses Observed Under Blockade of E2 (Letrozole) and E2 Plus DHT (Letrozole Plus Finasteride) Syntheses Across Different Stimulation Protocols {#s3-5}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------

The partial LTPs observed under combined blockade of E2 and DHT synthesis were compared across all different stimulus protocols (LFS, MFS, WFS and HFS). A small enhancement of LTP amplitude appeared at higher frequencies, but the differences were significant only between LFS-LTP and LTP induced by MFS and HFS (Tukey's *post hoc* test: LFS vs. WFS, *p* = 0.1, LFS vs. MFS, *p* \< 0.05, LFS vs. HFS, *p* \< 0.05, WFS vs. MFS, *p* = 0.93, WFS vs. HFS, *p* = 0.83, MFS vs. HFS, *p* = 0.99, Figure [6](#F6){ref-type="fig"}). Moreover, the responses under blockade of E2 synthesis alone significantly changed passing from full LTD by LFS to an increasing LTP at WFS, MFS and HFS (Tukey's *post hoc* test: LFS vs. WFS, *p* \< 0.001, LFS vs. MFS, *p* \< 0.001, LFS vs. HFS, *p* \< 0.001, WFS vs. MFS, *p* \< 0.05, WFS vs. HFS, *p* \< 0.05, MFS vs. HFS, *p* = 0.99, Figure [6](#F6){ref-type="fig"}).

![**Comparison of the responses induced by different stimulation patterns under combined blockade of E2 and DHT synthesis and under block of E2 alone.** The amplitude of the responses induced by LFS, WFS, MFS and HFS are compared under FIN + LET (white columns, one-way ANOVA, *F*~3,27~ = 3.39, Tukey's *post hoc* test \**p* \< 0.05) and under LET alone (hatched gray columns, one-way ANOVA, *F*~3,30~ = 50.34, *p* \< 0.0001, Tukey's *post hoc* test \*\**p* \< 0.001, \**p* \< 0.05). The graph also reports the difference between the values observed under combined and single block (two headed arrow and number) for revealing the inhibitory contribution of DHT at the different stimulation frequencies. Note the progressive decrease of the DHT influence.](fncel-09-00376-g0006){#F6}

The comparison of the responses observed under combined and single block across all stimulation patterns allows the evaluation of the inhibitory effect of the DHT at different stimulation frequencies. The DHT inhibition was indeed computable by subtracting the amplitude of the responses under letrozole from that under finasteride plus letrozole. The inhibitory influence, as resulting from this computation, was present throughout all stimulus patterns, but diminished progressively by increasing the stimulus frequency (LFS: 77.8%, WFS: 48.3%, MFS: 37.3%, HFS: 36.3%, Figure [6](#F6){ref-type="fig"}). In fact, the amplitude of responses under letrozole significantly increased showing a large change passing from LFS to HFS, while the partial LTP obtained under combined block of E2 and DHT showed a minor change that was significant only between LFS and MFS or HFS (Figure [6](#F6){ref-type="fig"}).

Discussion {#s4}
==========

This study demonstrates that the neo-syntheses of DHT and E2 during synaptic stimulation are crucial for the development and the sign of the long-term synaptic modification in the hippocampus CA1 region of male rat. In fact, the LTD and DP induced by LFS were prevented by finasteride, a blocking agent for the 5α-reductase enzyme converting T into DHT, while LTP induced by HFS was markedly reduced by letrozole, an inhibitor of the P450-aromatase mediating conversion of T into E2.

About the long-term effects of LFS, LTD induced in naïve neurons was fully prevented by finasteride, and a small LTP, instead, was evoked (Figure [7A](#F7){ref-type="fig"}). In addition, finasteride precluded the LFS-DP in neurons previously potentiated by HFS. The role of DHT synthesis was confirmed by the rescue of LTD and DP yielded by high concentration (50 nM) of DHT administered in the presence of finasteride, while lower concentration (10 nM) was inefficacious.

![**Schematic draw showing the different influence of neo-synthesized DHT and E2 on the LFS-LTD and HFS-LTP. (A)** LTD is induced in the presence of basal DHT synthesized by 5α-reductase enzyme from T (thin up arrow) and/or DHT synthesized by LFS (dashed arrow, thick up arrow). DHT exerts an inhibitory effect reverting the basal partial LTP (pLTP) into LTD. Synthesis of E2 is not involved in the LFS-LTD. but the exogenous E2 can enhance the pLTP to a full LTP. **(B)** pLTP is changed into a full LTP in the presence of basal E2 synthesized from T by P450-aromatase (thin up arrow) and/or E2 synthesized by HFS (dashed arrow, thick up arrow). The minor inhibitory effect of DHT on pLTP (thin arrow) might be prevented by an inhibitory influence of E2 on DHT (dotted arrow).](fncel-09-00376-g0007){#F7}

Considering that the basal synaptic activity was not influenced by exogenous DHT, we conclude that the block of DHT neo-synthesis definitely affects LTD and DP by interacting with their induction mechanism. Conversely, the synthesis of DHT was not implied in the maintenance of LTD since finasteride did not modify LTD, once settled.

Actually, the 5α-reductase is also implied in the synthesis of other neurosteroids, like the tetrahydrodeoxycorticosterone (THDOC) and allopregnanolone (ALLO) that are facilitatory allosteric modulators of GABA~A~ receptors (Lambert et al., [@B40]; Reddy, [@B59]). However, the androgenic neurosteroids have certainly a determinant role in the induction of LTD and DP since these long-term synaptic changes produced by LFS were also fully prevented by the blockade of ARs (Pettorossi et al., [@B55]). For the same reason, we exclude the influence of the DHT metabolites such as Adiol, which is reported to interfere with GABAA-mediated GABAergic transmission (Frye et al., [@B22]; Edinger et al., [@B16]; Reddy, [@B60]; Reddy and Jian, [@B61]).

Conversely, since ARs can bind both DHT and T, the involvement of T in LTD might be proposed. However, the finding that exogenously administered T, differently from DHT, was not able to rescue the LTD under finasteride, excludes T participation. To justify this diverse influence we took into account the lower receptor affinity of T compared with DHT (Zhou et al., [@B77]; Fang et al., [@B17]), which might also explain why the upstream accumulation of T, occurring under block of DHT synthesis, was not able to substitute for the lack of DHT.

We also examined the possible role of the neo-synthesis of E2 in the LFS depressive responses by applying letrozole. Both LFS-LTD and DP were not affected by letrozole, suggesting that E2 has no influence in the induction of these phenomena. In addition, under letrozole, we did not observe any enhancement of LTD and DP, as expected in the case of increase of DHT synthesis due to upstream accumulation of T. This suggests that the DHT-dependent LFS effects are not influenced by additional DHT, as also supported by the inability of exogenous DHT to modify the LFS-LTD.

Although E2 is not implied in the LFS-LTD, administration of E2 was indeed able to revert LTD into a robust LTP (Figure [7A](#F7){ref-type="fig"}). This suggests that the plastic events induced by LFS may be influenced by E2, but this influence is not normally possible due to a too low level of basally synthesized E2 and/or the stimulus inability to increase it. Unlike LTD and DP, E2 neo-synthesis is relevant for the full induction of the LTP (Grassi et al., [@B27]; Tanaka and Sokabe, [@B71]; Figure [7B](#F7){ref-type="fig"}), while it does not influence LTP maintenance (Grassi et al., [@B27]). Here, we found that under blockade of P450-aromatase the application of 1 or 0.5 nM E2 fully rescued LTP, enhancing its amplitude to values even higher than the control one. This rescue was not due to normal increase of the baseline induced by exogenous E2 since similar LTP was observed after lowering the stimulus intensity to recover the pre-E2 baseline.

Another point of interest concerns the role of DHT in HFS-LTP. Blockade of DHT synthesis during HFS induced a remarkable enhancement of the LTP amplitude. Is this evidence for a persistent influence of an inhibitory role of DHT at HFS, or is it the result of enhanced synthesis of E2 due to upstream accumulation of T? The fact that, differently from finasteride, AR antagonism did not change the amplitude of HFS-LTP (Pettorossi et al., [@B55]) straightforwardly supports the effect of T accumulation. However, the LTP obtained under combined block of E2 and DHT synthesis was higher than that observed under letrozole alone, suggesting the presence of an inhibitory DHT influence. It is likely that this influence is prevented or masked when the E2 synthesis is allowed (Figure [7B](#F7){ref-type="fig"}).

The contribution of E2 and DHT has been also examined on the responses induced by intermediate stimulation frequencies: WFS (1 s-25 Hz) and MFS (1 s-50 Hz). WFS elicited a small LTP that was enhanced by finasteride, but unaffected by letrozole, as occurs for the LFS-LTD. Conversely, MFS elicited a LTP that was similar to that induced by HFS and similarly was reduced by letrozole, but, at variance, not enhanced by finasteride.

This different effect might be due to the inability of MFS to drive a further synthesis of E2 from the T accumulated following the block of DHT synthesis. These results support the idea of a frequency dependent T-E2 conversion that is less powerful or null at lower frequencies.

On the whole, a basal partial LTP is only inducible, independently of stimulation pattern (LFS, WFS, MFS and HFS), under combined blockade of E2 and DHT synthesis. It is, in fact, the synthesis of E2 responsible for the enhancement of this basal LTP to a full LTP following MFS and HFS, and that of DHT that reverts the LTP into LTD following LFS. In contrast, with the influence of E2 that is only limited to the range of higher stimulation frequencies, DHT is maximally operative in the range of low frequencies, but its effect persists, even if with minor extent, across all tested frequencies. The amount of the DHT effect is detectable by computing the difference between the amplitude of LTP under combined blocks and under block of E2 synthesis alone.

The reason for a frequency dependent differential effect of E2 and DHT might be related to the specific interaction between the stimulus frequency and the basally synthesized neurosteroids, or to a specific capability of the stimulation patterns to increase neurosteroid synthesis depending on their frequency (Figure [7](#F7){ref-type="fig"}).

The frequency dependent activation of P450-aromatase and 5α-reductase on synaptic transmission is conceivable since different levels of Ca^2+^ entry modulated by the nervous activity (Kimoto et al., [@B38]; Balthazart and Ball, [@B1]; Hojo et al., [@B34]) may influence the enzymatic function. It is known, in fact, that LTP or LTD is driven by different velocity and amount of NMDAR-mediated Ca^2+^ increase (Dudek and Bear, [@B14]; Bear and Malenka, [@B6]; Cummings et al., [@B13]). In line with this evidence, we suggest that while DHT synthesis, even if it seems to be activated by a broad range of frequencies, is mostly enhanced by low frequency inducing a low Ca^2+^ entry (Dudek and Bear, [@B14]; Bear and Malenka, [@B6]; Cummings et al., [@B13]), E2 synthesis is triggered by HFS inducing high Ca^2+^ entry. However, the possible enzymatic activation of P450-aromatase by high Ca^2+^ entry is in contrast with data in the literature. In fact, a rapid inhibition of P450-aromatase, via a Ca^2+^-dependent phosphorylation, has been evidenced following increases of intracellular Ca^2+^ due to K^+^-induced depolarization or activation of glutamatergic receptors (Balthazart et al., [@B2], [@B4], [@B3]; Charlier et al., [@B11]). This prompts for a reduction of E2 synthesis during HFS. Conversely, our study suggests that the increase of E2 neo-synthesis should be driven by HFS, while increase of DHT neo-synthesis by LFS. To overcome this divergence, we propose that the velocity of Ca^2+^ entry following synaptic activation is a crucial point influencing differently phosphorilation-dephosphorilation processes for activating P450-aromatase or 5α-reductase enzymes.

Concerning the mechanisms through which new synthesized estrogenic and androgenic neurosteroids lead to long-term synaptic changes, we suggest that the activation of ERs and ARs might produce a functional up- or down-regulation of the NMDARs, respectively (Pouliot et al., [@B57]; Foy et al., [@B21]; Smith and McMahon, [@B65], [@B66]; Grassi et al., [@B26]) and influence the GABAergic neurotransmission in opposite ways, by interacting with the GABARs (Murphy et al., [@B52]; Frye et al., [@B22]; Rudick and Wooley, [@B62]; Edinger et al., [@B16]).

The influence of androgenic and estrogenic signals is probably exerted at postsynaptic level, as blockade of either ARs or ERs did not affect the facilitated responses to paired stimuli (Pettorossi et al., [@B55]).

Despite the need of further insight of the site and mechanism of neurosteroids in the synaptic plasticity, the current study puts forward a crucial function of neo-synthesized E2 and DHT in the induction and direction of the hippocampal synaptic plasticity.

Since our study has been performed only in male rat, we should be cautious in generalizing these mechanisms as it may vary depending on sex, estrous cycle and age, as shown in the vestibular system (Pettorossi et al., [@B56]; Grassi et al., [@B25]).

However, in this work we definitely demonstrated that specific stimulation patterns within the CNS are able to determine the amplitude and the sign of long-term synaptic effects through the neo-synthesis of E2 or DHT. Neural E2 and DHT should thus be recognized as very effective central modulators of synaptic plasticity that may significantly contribute to learning and memory performance.
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ARs

:   androgen receptors

DHT

:   5α-dihydrotestosterone

DP

:   depotentiation

E2

:   17b-estradiol

ERs

:   estrogen receptors

fEPSP

:   field excitatory postsynaptic potential
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:   finasteride
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:   letrozole
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LTD
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LTP
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NMDAR
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:   weak frequency stimulation.
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